天然产物研究与开发 ›› 2026, Vol. 38 ›› Issue (8): 1670-1678.doi: 10.16333/j.1001-6880.2026.8.005 cstr: 32307.14.1001-6880.2026.8.005

• 研究论文 • 上一篇    下一篇

牡荆苷调节AMPK/SIRT1信号通路对糖尿病视网膜病变大鼠血管生成、氧化损伤的影响

王  烁1*,陈铭军1,张伟明2,辛广宇3   

  1. 1齐齐哈尔市中医医院,齐齐哈尔 161000;2佳木斯大学基础医学院,佳木斯 154007;3齐齐哈尔医学院附属第二医院,齐齐哈尔 161006
  • 出版日期:2026-08-27 发布日期:2026-08-26
  • 基金资助:
    黑龙江省中医药科研课题(ZHY2022-044)

Effects of vitexin on angiogenesis and oxidative damage in rats with diabetic retinopathy by regulating AMPK/SIRT1 signaling pathway

WANG Shuo1*,CHEN Ming-jun1,ZHANG Wei-ming2,XIN Guang-yu3   

  1. 1Hospital of Traditional Chinese Medicine of Qiqihar,Qiqihar 161000,China;2School of Basic Medicine,Jiamusi University,Jiamusi 154007,China;3The Second Affiliated Hospital of Qiqihar Medical University,Qiqihar 161006,China
  • Online:2026-08-27 Published:2026-08-26

摘要:

本文探讨牡荆苷(vitexin,Vit)调节腺苷酸活化蛋白激酶/沉默信息调节因子1(adenosine monophosphate activated protein kinase/silent information regulator 1,AMPK/SIRT1)信号通路对糖尿病视网膜病变(diabetic retinopathy,DR)大鼠血管生成、氧化损伤的影响。构建DR大鼠,随机将大鼠分为正常组、模型组、Vit低剂量组、Vit高剂量组、羟苯磺酸钙阳性对照组、Vit高剂量+AMPK抑制剂BML-275组,每组12只;检查大鼠体质量和空腹血糖(fasting blood glucose,FBG);ELISA法检测氧化应激及炎症指标水平;荧光素眼底血管造影术检测视网膜血管生成情况;PAS染色观察视网膜微血管变化;HE染色观察视网膜组织病理变化;分子对接分析Vit与血管生成及AMPK/SIRT1通路蛋白的结合能力;Western blot法检测血管生成及AMPK/SIRT1通路蛋白表达。结果显示,Vit低剂量组、Vit高剂量组、阳性对照组较模型组视网膜组织结构损伤减轻,荧光素渗漏平均光密度值、微血管生成数、FBG、血清白细胞介素-6(interleukin-6,IL-6)、肿瘤坏死因子α(tumor necrosis factor α,TNF-α)、脂质过氧化物(lipid peroxidation,LPO)、总抗氧化能力(total antioxidant capacity,T-AOC)水平及视网膜组织缺氧诱导因子-1亚基α(hypoxia inducible factor-1 subunit α,HIF-1α)、血管内皮生长因子(vascular endothelial growth factor,VEGF)、细胞间黏附分子1(intercellular adhesion molecule-1,ICAM-1)蛋白表达降低(P<0.01),体质量及视网膜组织p-AMPK/AMPK、SIRT1蛋白表达升高(P<0.05);BML-275逆转了Vit高剂量组对DR大鼠血管生成、氧化损伤及炎症反应的抑制作用,进一步加重了视网膜组织病理损伤(P<0.01);Vit与AMPK、SIRT1、HIF-1α、VEGF、ICAM-1的结合能力均较好。总之,Vit可能通过激活AMPK/SIRT1信号通路改善DR大鼠血管生成、氧化损伤。

关键词: 牡荆苷, AMPK/SIRT1, 糖尿病视网膜病变, 血管生成, 氧化损伤

Abstract:

This study explores the impacts of vitexin (Vit) on angiogenesis and oxidative damage in rats with diabetic retinopathy (DR)  by adjusting adenosine monophosphate activated protein kinase/silent information regulator 1 (AMPK/SIRT1) signaling pathway. DR rats were constructed and randomly assigned into a normal group, a model group, a low-dose Vit group, a high-dose Vit group, a calcium dobesilate positive control group, and a high-dose Vit+AMPK inhibitor BML-275 group, each had 12 rats. The changes in body mass and fasting blood glucose (FBG) of rats were examined. ELISA method was used to detect oxidative stress and inflammatory markers. Fluorescein fundus angiography was performed to detect retinal angiogenesis. PAS staining was performed to observe changes in retinal microvasculature. HE staining was used to observe pathological changes in retinal tissue. Molecular docking analysis of Vit's binding ability to proteins involved in angiogenesis and the AMPK/SIRT1 pathway. Western blot was used to measure angiogenesis and AMPK/SIRT1 pathway proteins. Results show that compared with the model group, the low-dose Vit group, high-dose Vit group, and positive control group showed reduced retinal tissue structure damage, decreased neovascularization, more uniform vascular diameter, reduced the average optical density value of fluorescein leakage, microvascular generation, FBG, serum interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), lipid peroxidation (LPO), total antioxidant capacity (T-AOC) levels, and retinal tissue hypoxia inducible factor-1 subunit α (HIF-1α), vascular endothelial growth factor (VEGF), and intercellular adhesion molecule-1 (ICAM-1) proteins (P<0.01), and increased body weight, retinal tissue p-AMPK/AMPK and SIRT1 proteins (P<0.05). BML-275 reversed the inhibitory effects of high-dose Vit group on angiogenesis, oxidative damage, and inflammatory response in DR rats, further exacerbating pathological damage to retinal tissue (P<0.01). The binding capacity of Vit to AMPK, SIRT1, HIF-1α, VEGF, ICAM-1 are all relatively good. In conclusion, Vit may improve angiogenesis and oxidative damage in DR rats by activating the AMPK/SIRT1 signaling pathway.

Key words:

vitexin; AMPK/SIRT1, diabetic retinopathy, angiogenesis, oxidative damage

中图分类号:  R285.5